FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 151 through 200 of 301

BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES - SIC # 2836

Ticker Exchange Company Financial Reports SIC #
IOVA Nasdaq Iovance Biotherapeutics, Inc. 2836
IPHA Nasdaq Innate Pharma S.A. 2836
IRWD Nasdaq Ironwood Pharmaceuticals, Inc. 2836
IVVD Nasdaq Invivyd, Inc. 2836
JBIO Nasdaq Jade Biosciences, Inc. 2836
KALA Nasdaq KALA BIO, Inc. 2836
KLRA Nasdaq Kailera Therapeutics, Inc. 2836
KLRS Nasdaq Kalaris Therapeutics, Inc. 2836
KNSA Nasdaq Kiniksa Pharmaceuticals International, p 2836
KRRO Nasdaq Korro Bio, Inc. 2836
KRSA Nasdaq Korsana Biosciences, Inc. 2836
KTTA Nasdaq Pasithea Therapeutics Corp. 2836
LCTX NYSE American Lineage Cell Therapeutics, Inc. 2836
LEGN Nasdaq Legend Biotech Corporation 2836
LGVN Nasdaq Longeveron Inc. 2836
LMAT Nasdaq LeMaitre Vascular, Inc. 2836
LNAI Nasdaq Lunai Bioworks Inc. 2836
LONA Nasdaq LeonaBio, Inc. 2836
LTGO Nasdaq Latigo Biotherapeutics, Inc. 2836
LXEO Nasdaq Lexeo Therapeutics, Inc. 2836
LXRX Nasdaq Lexicon Pharmaceuticals, Inc. 2836
MBIO Nasdaq Mustang Bio, Inc. 2836
MBRX Nasdaq Moleculin Biotech, Inc. 2836
MBX Nasdaq MBX Biosciences, Inc. 2836
MDXG Nasdaq MiMedx Group, Inc. 2836
MESO Nasdaq Mesoblast Limited 2836
MGNX Nasdaq MacroGenics, Inc. 2836
MLYS Nasdaq Mineralys Therapeutics, Inc. 2836
MNKD Nasdaq MannKind Corporation 2836
MNOV Nasdaq MediciNova, Inc. 2836
MNPR Nasdaq Monopar Therapeutics Inc. 2836
MRNA Nasdaq Moderna, Inc. 2836
MXCT Nasdaq MaxCyte, Inc. 2836
MYGN Nasdaq Myriad Genetics, Inc. 2836
NBIX Nasdaq Neurocrine Biosciences, Inc. 2836
NBP Nasdaq NovaBridge Biosciences 2836
NCEL Nasdaq NewcelX Ltd. 2836
NERV Nasdaq Minerva Neurosciences, Inc. 2836
NIKI Nasdaq Niki BioSolutions, Inc. 2836
NKTX Nasdaq Nkarta, Inc. 2836
NNNN Nasdaq Anbio Biotechnology 2836
NRIX Nasdaq Nurix Therapeutics, Inc. 2836
NVAX Nasdaq Novavax, Inc. 2836
NVCT Nasdaq Nuvectis Pharma, Inc. 2836
OABI Nasdaq OmniAb, Inc. 2836
OBX Nasdaq Obsidian Therapeutics, Inc. 2836
OCGN Nasdaq Ocugen, Inc. 2836
OKUR Nasdaq OnKure Therapeutics, Inc. 2836
OKYO Nasdaq OKYO Pharma Limited 2836
ONCY Nasdaq Oncolytics Biotech Inc. 2836
Results 150 through 200 of 301